Your session is about to expire
← Back to Search
Concentrated Investment for Health Disparities in Black Neighborhoods
N/A
Waitlist Available
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
At least 18 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up quarterly data from 24 months (8 quarters) prior to enrollment and 12 months (4 quarters) after intervention period complete
Awards & highlights
Study Summary
This trial will test a "big push" intervention of place-based and financial-wellbeing interventions in 60 Black neighborhoods in Philadelphia, with the goal of reducing racial health disparities.
Who is the study for?
This trial is for Black Americans at least 18 years old living in certain Philadelphia neighborhoods. Participants must be able to text, speak English, reside permanently in their homes, and understand their household finances. Those planning to move soon or unable to consent are excluded.Check my eligibility
What is being tested?
The study tests a 'big push' intervention aimed at improving health by enhancing financial well-being and investing in neighborhood environments. It includes greening lots, fixing houses, planting trees, cleaning trash, financial counseling, tax help, and emergency cash aid.See study design
What are the potential side effects?
Since this isn't a medical trial but an intervention on social determinants of health involving community investment and financial support services, traditional side effects aren't expected; however participants may experience changes in stress levels or well-being.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ quarterly data from 24 months (8 quarters) prior to enrollment and 12 months (4 quarters) after intervention period complete
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~quarterly data from 24 months (8 quarters) prior to enrollment and 12 months (4 quarters) after intervention period complete
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Overall Health Index
Psychological Distress
Secondary outcome measures
Change in overall health
Financial well-being
Food insecurity
+26 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment2 Interventions
At the individual level, participants in the intervention arm receive place-based and financial well-being interventions.
These include, at the individual level:
Tax preparation
Access to public benefits
Financial counseling and microgrants
At the neighborhood level:
Abandoned house remediation
Trash cleanup
Vacant lot greening
Tree planting
Group II: ControlActive Control1 Intervention
Participants in the control arm will not receive any of the listed interventions.
Find a Location
Who is running the clinical trial?
University of PennsylvaniaLead Sponsor
2,016 Previous Clinical Trials
42,873,525 Total Patients Enrolled
7 Trials studying Health Behaviors
182,939 Patients Enrolled for Health Behaviors
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am unable to fully understand or agree to the study on my own.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger